Tumor Ablation Market is expected to grow at a CAGR of 13.10% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, the global Tumor Ablation Market size accounted for USD 1.67 billion in 2022, growing at a CAGR of 13.10% from 2023 to 2033. The Tumor Ablation Market involves the use of minimally invasive procedures to destroy or eliminate cancerous tumors. Utilizing techniques such as radiofrequency ablation, microwave ablation, and cryoablation, this market aims to provide alternatives to traditional surgery for tumor treatment. Key drivers include the increasing incidence of cancer, technological advancements in ablation procedures, and a growing preference for minimally invasive interventions. Major players offer a range of tumor ablation devices and systems to address the diverse needs of oncology patients.
Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021361
The Tumor Ablation Market is propelled by a rising demand for minimally invasive cancer treatment options, utilizing techniques like radiofrequency and microwave ablation. Key drivers include the growing incidence of cancer, advancements in ablation technologies, and a preference for less invasive procedures. Major market players provide diverse tumor ablation devices, offering effective alternatives to traditional surgical interventions.
Key Players
Some of the major Tumor Ablation Market players holding high market shares include Medtronic; Boston Scientific Corp.; Johnson & Johnson Service Inc. (Ethicon, Inc.) and AngioDynamics. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Bioventus Inc. (Misonix Inc.); EDAP TMS; Chongqing Haifu Medical Technology Co., Ltd.; Mermaid Medical; HealthTronics, Inc.; H.S. Hospital Service S.p.A.
Report Description: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021361
Segmental Analysis
Based on Technology, the Tumor Ablation market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, HIFU and Other ablation technologies. In 2023, the radiofrequency tumor ablation category accounted for the greatest proportion, with 32.7%. Its advantages, like specificity and efficiency in solid tumor ablation treatments in the kidney and liver, might be linked to its supremacy.
Based on Treatment, the Tumor Ablation market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. With a market share of over 56.7% in 2023, the percutaneous ablation category led the industry. There is less scarring, a quicker recovery, and more safety with these operations. Furthermore, it is projected that elements like patient comfort, speedy surgical times, and cost effectiveness will increase demand in this market.
Based on Application, the Tumor Ablation market is segmented into Kidney Cancer, Liver cancer, Breast cancer, Lung cancer, Prostate cancer and Other cancer. In 2023, other market categories took the lead with a revenue share of roughly 28.8%. This section covers a variety of cancers, including ENT cancer and cancer with bone metastases. It is projected that the prevalence of cancer is rising and that the availability of sophisticated techniques will support sector expansion.
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.

This release was published on openPR.